Viral reactivation in hospitalized patients with drug reaction with eosinophilia and systemic symptoms: A retrospective study from a tertiary medical center in the United States - 19/06/20
Doi : 10.1016/j.jaad.2020.03.095
Nima Milani-Nejad, MD, PhD ⁎ 
, John Trinidad, MD, MPH, Benjamin H. Kaffenberger, MD
, John Trinidad, MD, MPH, Benjamin H. Kaffenberger, MD Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus
∗Correspondence to: Nima Milani-Nejad, MD, PhD, 540 Officenter Place, Suite 240, Gahanna, OH 43230540 Officenter Place, Suite 240GahannaOH43230
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Reviewed and approved by the IRB of The Ohio State University. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 1
P. 278-279 - juillet 2020 Retour au numéro
Article précédent
- Spironolactone for treatment of female pattern hair loss
- Laura J. Burns, Brianna De Souza, Elizabeth Flynn, Dina Hagigeorges, Maryanne M. Senna
- Back to the basics: Diluted bleach for COVID-19
- Parth Patel, Sanjna Sanghvi, Kunal Malik, Amor Khachemoune
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?